FDA
approval
· 2023-03-24
FDA Approved: LOJAIMIESS — Supplemental Application (Xiromed LLC)
Summary
FDA approved a supplemental application for LOJAIMIESS (levonorgestrel and ethinyl estradiol tablets) from Xiromed LLC. The product is a generic combined oral c…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for LOJAIMIESS (LEVONORGESTREL AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL TABLETS)